Skip to main content
logo
iTeos Therapeutics, Inc. (ITOS)
10.15
+0.02 (0.20%)
Inactive · Last trade price on Aug 28, 2025

iTeos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
4492813926951,6421,185
Market Cap Growth
--28.39%-43.60%-57.70%38.57%-
Enterprise Value
-62-203-201-53745845
Last Close Price
10.157.6810.9519.5346.5633.82

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PE Ratio
---7.197.66-
Forward PE
----10.82-
PS Ratio
-8.0231.112.604.76-
PB Ratio
0.790.480.681.052.973.67
P/TBV Ratio
0.910.480.681.052.973.67
P/FCF Ratio
----3.21-
P/OCF Ratio
----3.20-

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
----2.16-
EV/EBITDA Ratio
----3.04-
EV/EBIT Ratio
----3.04-
EV/FCF Ratio
----1.46-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.010.010.010.010.01-
Debt / EBITDA Ratio
---0.040.02-
Debt / FCF Ratio
----0.01-
Asset Turnover
-0.050.020.330.56-
Quick Ratio
7.3712.3513.4614.662.8322.45
Current Ratio
7.5312.6313.7614.962.8822.64
Return on Equity (ROE)
-34.97%-23.06%-18.19%15.90%48.98%-22.45%
Return on Assets (ROA)
-18.49%-14.47%-12.97%9.72%24.90%-14.97%
Return on Invested Capital (ROIC)
-21.76%-16.66%-14.77%13.00%34.73%-16.58%
Return on Capital Employed (ROCE)
---17.90%42.20%-

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-45.11%-47.91%-28.75%13.91%13.06%-3.21%
FCF Yield
-24.23%-35.57%-27.24%-16.14%31.17%-2.15%
Buyback Yield / Dilution
-17.71%-13.17%5.30%0.02%-150.49%-7336.28%
SEC Filings: 10-K · 10-Q